Edition:
India

China NT Pharma Group Company Ltd (1011.HK)

1011.HK on Hong Kong Stock

0.78HKD
14 Jun 2019
Change (% chg)

HK$0.01 (+1.30%)
Prev Close
HK$0.77
Open
HK$0.78
Day's High
HK$0.80
Day's Low
HK$0.77
Volume
952,000
Avg. Vol
2,088,231
52-wk High
HK$2.01
52-wk Low
HK$0.54

Latest Key Developments (Source: Significant Developments)

China NT Pharma Group Co Posts FY Loss Attributable Rmb957.7 Mln
Friday, 29 Mar 2019 

March 29 (Reuters) - China NT Pharma Group Co Ltd <1011.HK>::FY LOSS ATTRIBUTABLE RMB957.7 MILLION VERSUS PROFIT OF RMB165.2 MILLION.FY REVENUE FROM CONTINUING OPERATIONS RMB571.5 MILLION VERSUS RMB604.8 MILLION.  Full Article

China NT Pharma Group Announces Termination Of Letter Of Intent In Relation To Possible Disposal
Friday, 1 Mar 2019 

March 1 (Reuters) - China NT Pharma Group Co Ltd <1011.HK>::UPDATES ON UNIT'S PROPOSED DISPOSAL OF CERTAIN STAKE IN SUZHOU FIRST PHARMACEUTICAL TO BROTHER ENTERPRISES.ANNOUNCES TERMINATION OF LETTER OF INTENT IN RELATION TO A POSSIBLE DISPOSAL AS BOTH PARTIES FAILED TO REACH AN AGREEMENT.  Full Article

China NT Pharma Group Co Announces Placing Of Up To Hk$100 MLN Bonds
Friday, 25 Jan 2019 

Jan 25 (Reuters) - China NT Pharma Group Co Ltd <1011.HK>::ANNOUNCES PLACING OF UP TO HK$100 MILLION BONDS.ISSUE PRICE REPRESENTS 100% OF PRINCIPAL AMOUNT OF BONDS.  Full Article

China NT Pharma Group Co Posts HY Profit Attributable RMB82.9 Mln
Tuesday, 21 Aug 2018 

Aug 21 (Reuters) - China NT Pharma Group Co Ltd <1011.HK>::HY REVENUE FROM CONTINUING OPERATIONS RMB312 MILLION VERSUS RMB314.4 MILLION.HY PROFIT ATTRIBUTABLE RMB82.9 MILLION VERSUS RMB80.7 MILLION.  Full Article

China NT Pharma Group Co Appoints Wang Fei As CFO
Friday, 6 Apr 2018 

April 6 (Reuters) - China NT Pharma Group Co Ltd <1011.HK>::CHIU YU KANG RESIGNED AS CHIEF FINANCIAL OFFICER.‍APPOINTS WANG FEI AS CFO.  Full Article

China NT Pharma Group Co says HY profit attributable to equity shareholders up 61.1 pct
Monday, 21 Aug 2017 

Aug 21 (Reuters) - China NT Pharma Group Co Ltd <1011.HK>::HY profit attributable to equity shareholders of company increased by 61.1% from RMB50.1 million to RMB80.7 million.HY overall revenue of group up 44.9 percent to RMB559.1 million.  Full Article